Filing Details
- Accession Number:
- 0001140361-22-044631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-06 18:52:09
- Reporting Period:
- 2022-12-02
- Accepted Time:
- 2022-12-06 18:52:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 748592 | Eterna Therapeutics Inc. | ERNA | Pharmaceutical Preparations (2834) | 311103425 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1828224 | Jason Nicholas Singer | C/O Eterna Therapeutics Inc. 10355 Science Center Drive, Suite 150 San Diego CA 92121 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-02 | 70,822 | $3.28 | 121,822 | No | 4 | P | Indirect | By Purchase Capital LLC |
| Common Stock | Acquisiton | 2022-12-02 | 212,464 | $3.28 | 266,214 | No | 4 | P | Indirect | By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Purchase Capital LLC |
| No | 4 | P | Indirect | By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.005 Per Share | Warrants (right to buy) | Acquisiton | 2022-12-02 | 141,644 | $0.13 | 141,644 | $3.28 |
| Common Stock, Par Value $0.005 Per Share | Warrants (right to buy) | Acquisiton | 2022-12-02 | 424,928 | $0.13 | 424,928 | $3.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 141,644 | 2023-06-02 | 2028-06-02 | No | 4 | P | Indirect |
| 424,928 | 2023-06-02 | 2028-06-02 | No | 4 | P | Indirect |
Footnotes
- The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.
Billionaire Hedge Funds
